GI Tract Mycobiome in Chronic Hepatitis C Virus Infection : A Case Control Study

2017 ◽  
Vol 26 (4) ◽  
pp. 81-87
Author(s):  
Ghada El-Saeed Mashaly ◽  
Amr Mohamed El-Sabbagh ◽  
Tarek Fouad Sheta
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Case Control Study ◽  
Case Control ◽  
Hepatitis C Virus Infection ◽  
Gi Tract ◽  
Chronic Hepatitis C Virus ◽  
Control Study

Risk factors in community-acquired chronic hepatitis C virus infection: a case-control study in Italy

1996 ◽  
Vol 24 (2) ◽  
pp. 129-134 ◽  
Author(s):  
Maria Chiaramonte ◽  
Tommaso Stroffolini ◽  
Umberto Lorenzoni ◽  
Francesco Minniti ◽  
Susanna Conti ◽  
...  
Keyword(s):  
Risk Factors ◽  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Case Control Study ◽  
Case Control ◽  
Hepatitis C Virus Infection ◽  
Chronic Hepatitis C Virus ◽  
Control Study

scholarly journals Surgical procedures as a major risk factor for chronic hepatitis C virus infection in Italy: Evidence from a case-control study

1999 ◽  
Vol 3 (4) ◽  
pp. 207-210 ◽  
Author(s):  
Giovanni B. Gaeta ◽  
Tommaso Stroffolini ◽  
Gloria Taliani ◽  
Francesca Menniti Ippolito ◽  
Giuseppe Giusti ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Risk Factor ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Case Control Study ◽  
Case Control ◽  
Hepatitis C Virus Infection ◽  
Chronic Hepatitis C Virus ◽  
Control Study

Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: Results of a case-control study

Hepatology ◽  
1997 ◽  
Vol 26 (3) ◽  
pp. 776-779 ◽  
Author(s):  
L Serfaty ◽  
O Chazouilleres ◽  
A Poujol-Robert ◽  
L Morand-Joubert ◽  
C Dubois ◽  
...  
Keyword(s):  
Risk Factors ◽  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Case Control Study ◽  
Case Control ◽  
Hepatitis C Virus Infection ◽  
Chronic Hepatitis C Virus ◽  
Control Study

Chronic hepatitis C virus infection and genitourinary cancers: A case-control study

2020 ◽  
Vol 47 (2-3) ◽  
pp. 165-167
Author(s):  
Georgios Angelidakis ◽  
Parag Mahale ◽  
Eric Jonasch ◽  
Ying Jiang ◽  
Harrys A. Torres
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Case Control Study ◽  
Case Control ◽  
Hepatitis C Virus Infection ◽  
Chronic Hepatitis C Virus ◽  
Genitourinary Cancers ◽  
Control Study

scholarly journals Effectiveness and safety of ombitasvir/paritaprevir/ritonavir in treatment of chronic hepatitis C Egyptian hemodialysis patients, case-control study

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Nahla Mohamed Teama ◽  
Waleed Anwar Abdel-Mohsen ◽  
Ossama Ashraf Ahmed ◽  
Sarah Mohamed El Sayed ◽  
Ahmed Mohamed ElGhandour
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Case Control Study ◽  
Hemodialysis Patients ◽  
Hepatitis C Virus Infection ◽  
Chronic Hepatitis C Virus ◽  
Kidney Functions ◽  
Control Study

Abstract Background Prevalence of hepatitis C virus infection in patients with renal diseases is higher compared to the general population. FDA has approved ombitasvir/paritaprevir/ ritonavir for the treatment of patients with severe renal disease. This study aimed to evaluate the efficacy and safety of ombitasvir/paritaprevir/ritonavir with or without ribavirin in treatment of chronic hepatitis C Egyptian hemodialysis patients to compare it with the same treatment result in chronic hepatitis C Egyptian patients with normal renal functions. This case-control study was conducted on one hundred patients with confirmed diagnosis of HCV-positive infection at the Center of National Committee for Control of Viral Hepatitis [NCCVH] at Ain Shams University Hospital. Patients were divided into two groups: group I (control group) with 50 chronic hepatitis C virus patients with normal renal functions and group II (Case Group) with 50 chronic hepatitis C virus hemodialysis patients. Results 95.1% of prevalent hemodialysis patients achieved sustained virological response (SVR), while 100% of patients with normal kidney functions achieved sustained virological response. Most common side effects were hemoglobin drop, gastrointestinal disturbance, severe fatigue, and itching. Conclusion Ombitasvir, paritaprevir, and ritonavir are considered a safe and effective in treatment in HCV infection in patients on regular hemodialysis as in chronic hepatitis C virus infection patients with normal kidney functions.

Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study

1996 ◽  
Vol 25 (10) ◽  
pp. 527-533 ◽  
Author(s):  
Marco Carrozzo ◽  
Sergio Gandolfo ◽  
Mario Carbone ◽  
Piero Colombatto ◽  
Roberto Broccoletti ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Oral Lichen Planus ◽  
Case Control Study ◽  
Case Control ◽  
Hepatitis C Virus Infection ◽  
Oral Lichen ◽  
Control Study ◽  
Prospective Case Control Study
Sign in / Sign up

Export Citation Format

Share Document